Lakshmi Ran Narasimhan - FDA Investigator Report

Overview Statistics

6
Total Inspections
5
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 12 days
Shortest Inspection: 5 days
Average Length: 8.7 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Lakshmi Ran Narasimhan's Recent Inspections

DateCompanyCityCountryFEI Number483
2018-05-15Exelead, Inc.IndianapolisUnited States1000517970
2017-04-07Biocon Biologics LimitedBengaluruIndia3003981475
2015-07-03Intas Pharmaceuticals LimitedAhmedabadIndia3007277149
2014-03-18Eli Lilly Kinsale Ltd.KinsaleIreland3002806888
2013-08-23GlaxoSmithKline, LLC.ConshohockenUnited States3004055938
2013-04-19Exelead, Inc.IndianapolisUnited States1000517970

Sign Up to get the complete report.

Download 483s and EIRs for Lakshmi Ran Narasimhan

Lakshmi Ran Narasimhan - Co-Inspectors

NameInspectionsLast Inspection
Bo Chi22018
Reyes Candau-Chacon22017
Jazmine N Still12018
Lindsey J Brown12017
Michael Shanks12017
Daniel J Roberts12015
Colleen Thomas12013
Kalavati C Suvarna12013
Larry K Austin12013
Meisha R Sampson12013

Lakshmi Ran Narasimhan's Active Locations

  • United States
  • India
  • Ireland

Lakshmi Ran Narasimhan's Year-wise Inspection Count

  • 2013:2 inspections
  • 2014:1 inspections
  • 2015:1 inspections
  • 2017:1 inspections
  • 2018:1 inspections
Last Updated: 2025-05-14 06:11:22